A detailed history of High Tower Advisors, LLC transactions in Haleon PLC stock. As of the latest transaction made, High Tower Advisors, LLC holds 225,407 shares of HLN stock, worth $2.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
225,407
Previous 305,783 26.29%
Holding current value
$2.16 Million
Previous $3.17 Million 36.25%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

SELL
$8.72 - $10.35 $700,878 - $831,891
-80,376 Reduced 26.29%
225,407 $2.02 Million
Q2 2025

Aug 11, 2025

SELL
$9.27 - $11.41 $328,148 - $403,902
-35,399 Reduced 10.38%
305,783 $3.17 Million
Q1 2025

May 12, 2025

SELL
$9.02 - $10.67 $193,957 - $229,437
-21,503 Reduced 5.93%
341,182 $3.51 Million
Q4 2024

Feb 07, 2025

BUY
$9.23 - $10.71 $109,744 - $127,341
11,890 Added 3.39%
362,685 $3.47 Million
Q3 2024

Nov 14, 2024

BUY
$8.32 - $10.7 $623,750 - $802,179
74,970 Added 27.18%
350,795 $3.71 Million
Q2 2024

Aug 13, 2024

SELL
$8.01 - $8.64 $241,998 - $261,031
-30,212 Reduced 9.87%
275,825 $2.28 Million
Q1 2024

May 06, 2024

BUY
$8.02 - $8.67 $135,834 - $146,843
16,937 Added 5.86%
306,037 $2.6 Million
Q4 2023

Feb 12, 2024

BUY
$7.78 - $8.62 $530,806 - $588,116
68,227 Added 30.89%
289,100 $2.38 Million
Q3 2023

Nov 08, 2023

SELL
$7.85 - $8.94 $189,553 - $215,874
-24,147 Reduced 9.86%
220,873 $1.84 Million
Q2 2023

Aug 14, 2023

BUY
$8.04 - $9.0 $3,183 - $3,564
396 Added 0.16%
245,020 $2.05 Million
Q1 2023

May 11, 2023

SELL
$7.57 - $8.37 $50,938 - $56,321
-6,729 Reduced 2.68%
244,624 $1.99 Million
Q4 2022

Feb 08, 2023

BUY
$5.96 - $8.06 $19,268 - $26,057
3,233 Added 1.3%
251,353 $2.01 Million
Q3 2022

Nov 09, 2022

BUY
$5.63 - $7.5 $1.4 Million - $1.86 Million
248,120 New
248,120 $1.5 Million

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.3B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.